Cargando…
The severity of COVID-19 in children on immunosuppressive medication
Autores principales: | Marlais, Matko, Wlodkowski, Tanja, Vivarelli, Marina, Pape, Lars, Tönshoff, Burkhard, Schaefer, Franz, Tullus, Kjell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220160/ https://www.ncbi.nlm.nih.gov/pubmed/32411815 http://dx.doi.org/10.1016/S2352-4642(20)30145-0 |
Ejemplares similares
-
COVID-19 in children treated with immunosuppressive medication for kidney diseases
por: Marlais, Matko, et al.
Publicado: (2021) -
Impact of COVID-19 pandemic on use of rituximab among children with difficult nephrotic syndrome
por: Sinha, Rajiv, et al.
Publicado: (2021) -
Should we screen for intracranial aneurysms in children with autosomal dominant polycystic kidney disease?
por: Walker, Emma Y. X., et al.
Publicado: (2022) -
Catch-up growth in children with chronic kidney disease started on enteral feeding after 2 years of age
por: Marlais, Matko, et al.
Publicado: (2019) -
Survey on Management of Transition and Transfer From Pediatric- to Adult-based Care in Pediatric Kidney Transplant Recipients in Europe
por: Kreuzer, Martin, et al.
Publicado: (2018)